Medtronic strategic deal with CathWorks could lead to $585 million buyout


As part of the agreement, Medtronic will invest up to $75 million in the Israeli med-tech company, which has developed a diagnostic system that helps doctors evaluate the severity of coronary artery disease.

Previous St. Pete Pier nabs coveted ULI urban design award
Next Copper & Kings releases its first bourbon — here's how to get it